
Sign up to save your podcasts
Or
In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.
5
1818 ratings
In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.
90,911 Listeners
14 Listeners
68 Listeners
1 Listeners
1 Listeners
4 Listeners
8 Listeners
0 Listeners
1 Listeners
17 Listeners